Local Institution - 0030 — Chicago, Illinois

Local Institution - 0030 is a clinical research site located in Chicago, Illinois, United States 60611.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Local Institution - 0030 has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Untreated, Unresectable, or Metastatic Colorectal Cancer, Non-Squamous Cell Non-small Cell Lung Cancer.

Sponsors: Bristol-Myers Squibb.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution - 0030?

Local Institution - 0030 has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution - 0030 conducted?

Local Institution - 0030 has 2 clinical trials on record, with 1 currently active. Their work covers Untreated, Unresectable, or Metastatic Colorectal Cancer, Non-Squamous Cell Non-small Cell Lung Cancer.

Is Local Institution - 0030 accredited by Crixeo Health?

Local Institution - 0030 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Local Institution - 0030?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.